The relationship between 25 hydroxyvitamin D, parathyroid hormone levels and hypertension
CSTR:
Author:
Affiliation:

1.Department of Cardiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110000, China;2.Department of Cardiology, Shulan Hangzhou Hospital, Hangzhou, Zhejiang 310000, China)

Clc Number:

R544.1

  • Article
  • | |
  • Metrics
  • |
  • Reference [24]
  • |
  • Related
  • |
  • Cited by
  • | |
  • Comments
    Abstract:

    Aim To explore the direct correlation between serum levels of 25-hydroxyvitamin D[25-(OH)D], parathyroid hormone (PTH) and hypertension. Methods From March 2014 to July 5,8 patients inhospitalized in department of cardiology were selected. Based on the presence of hypertension, they were divided into hypertension group (198 cases) and non-hypertension group (170 cases). Demographic information was collected and blood samples were taken to probe levels of PTH and 25-(OH)D. Correlation between 25-(OH)D, PTH and hypertension were tested.Results Serum 25-(OH)D level of patients in hypertension group was lower than that in non-hypertension group (37.67±18.23 nmol/L vs 42.45±20.41 nmol/L,P=0.018). Difference in PTH of the two groups lacked statistical significance (50.08±28.80 ng/L vs 50.45±22.37 ng/L, P=0.892). Pearson correlation analysis showed that 25-(OH)D level was negatively correlated with PTH(r=-0.225,P<0.05). Multivariable logistic regression indicated that vitamin D deficiency was the independent risk factor of hypertension (OR=1.7,5%CI 1.138~2.996,P=0.013),whereas PTH showed no correlation with hypertension. Conclusion Vitamin D lack or deficiency has independent risk effect on hypertension.

    Reference
    [1] Holick M F.High prevalence of vitamin D inadequacy and implications for health.Mayo Clin Proc, 6,1:353-373.
    [2] Bouillon R, Carmeliet G, Verlinden L, et al.Vitamin D and human health:lessons from vitamin D receptor null mice.Endocr Rev, 8,9:726-776.
    [3] Wang T J, Pencina MJ, Booth SL, et al.Vitamin D deficiency and risk of cardiovascular disease.Circulation, 8,7:503-511.
    [4] Holick M F.Vitamin D deficiency .N Engl J Med, 7,7(3):266-281.
    [5] Meems L M, Vander Harst P, Van Gilst WH, et al.Vitamin D biology in heart failure:molecular mechanisms and systematic review.Current Drug Targets, 1,2(1):29-41.
    [6] Li YC, Qiao G, Uskokovic M, et al.Vitamin D:a negative endocrine regulator of the renin-angiotensin system and blood pressure.Steroid Biochem Mol Biol, 4,9-90(1-5):387-392.
    [7] 廖祥鹏, 张增利, 张红红, 等.维生素D与成年人骨骼健康应用指南(2014年标准版).中国骨质疏松杂志, 4,0(9):1 011-030.
    [8] Aspray TJ, Bowring C, Fraser W, et al.National osteoporosis society vitamin D guideline summary.Age Ageing, 4,3(5):592-595.
    [9] Judd S E, Tangpricha V.Vitamin D deficiency and risk for cardiovascular disease.Am J Med Sci, 9,8(1):40-44.
    [10] Carsten C, Campbell M J.Vitamin D receptor signaling mechanisms:Integrated actions of a well-defined transcription factor.Steroids, 3,8(2):127-136.
    [11] Medicine IO, Taylor CL, Yaktine AL, et al.Dietary reference intakes for calcium and vitamin D.National Academies Press, 1,4(14):1 427.
    [12] Ashwell M, Stone EM, Stolte H, et al.UK food standards agency workshop report:an investigation of the relative contributions of diet and sunlight to vitamin D status.Br J Nutr, 0,4(4):603-611.
    [13] Lips P, van Schoor NM, de Jongh RT.Diet, sun, and lifestyle as determinants of vitamin D status.Ann N Y Acad Sci, 4,7(5):92-98.
    [14] Bolland MJ, Grey A, Cundy T.Vitamin D and health in adults in Australia and New Zealand:a position statement .Med J Austr, 2,7 (10):553.
    [15] Malabanan A, Veronikis IE, Holick MF.Redefining vitamin D insufficiency.Lancet, 8,1(9105):805-806.
    [16] Feelisch M, Kolb BVD, Lundberg JO, et al.Is sunlight good for our heart?.Eur Heart J, 0,1(9):1 041-045.
    [17] Ke L, Mason RS, Mpofu E, et al.Vitamin D and parathyroid hormone status in a representative population living in Macau, China.J Steroid Biochem Mol Biol, 5,8:261-268.
    [18] Robert S, Sandy S, Stewart AW, et al.Long-term high-dose vitamin D3 supplementation and blood pressure in healthy adults:a randomized controlled trial.Hypertension, 4,4(4):725-730.
    [19] 张明琛, 徐新娟, 刘海明, 等.新疆维吾尔族成人维生素D水平及其与血压的关系.中华高血压杂志, 5,3(7):671-676.
    [20] 朱学创.维生素D和高血压发病的研究进展.中国动脉硬化杂志, 0,8(12):1 001-003.
    [21] Chen WR, Chen YD, Shi Y, et al.Vitamin D, parathyroid hormone and risk factors for coronary artery disease in a Chinese elderly population.J Cardiovasc Med (Hagerstown) J, 5,6(1):59-68.
    [22] Mao X, Zheng H, Liu Z, et al.Analysis of 25(OH)D serum concentrations of hospitalized elderly patients in the Shanghai area.Plos One, 4,9(3):e90 729.
    [23] Yan L, Prentice A, Zhang H, et al.Vitamin D status and parathyroid hormone concentrations in Chinese women and men from north-east of the People's Republic of China.Eur J Clin Nutr, 0,4(1):68-72.
    [24] Van Ballegooijen AJ, Kestenbaum B, Sachs MC, 等.25-羟维生素D和甲状旁腺激素与高血压的相关性.中华高血压杂志, 4,2(6):587-588.
    Related
    Cited by
Get Citation

FU Peng, ZHANG Lin, YANG Bo-Yi, NIU Tie-Sheng. The relationship between 25 hydroxyvitamin D, parathyroid hormone levels and hypertension[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2018,26(1):73-76, 108.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:August 28,2017
  • Revised:November 27,2017
  • Online: February 01,2018
Article QR Code